Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. REGDEX Other REGDEX
  5. 8-K Event Other events
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 8-K Event Material agreement · Unregistered share sale
  14. DEFR14A Other DEFR14A
  15. 8-K Event Other events
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. DEF 14A Proxy Proxy Statement
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. UPLOAD Other SEC-generated Letter

Page 56 of 72 · 1,429 filings